Podcast: Key takeaways from EASD 2026 on where GLP-1s are headed
The world of diabetes and obesity research has exploded in recent years with the blockbuster success of glucagon-like peptide (GLP)-1…
Analysis
Eli Lilly API Manufacturing Facility, Texas, US
GLP-1RA non-responders: tackling a hidden challenge behind the obesity epidemic
Magazine: Keep it cool
Lonza Commercial Spray-Drying Facility, Oregon, US
Stada Arzneimittel Supply Chain and Packaging Facility, Turda, Romania
Podcast: How Sandoz plans to harness its “golden decade”
The shrinking return on investment for Nordic innovation
